CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keil, U.
Right arrow Articles by Klinken, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keil, U.
Right arrow Articles by Klinken, S. P.

Cell Growth & Differentiation, Vol 6, Issue 4 439-448, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Emergence of myeloid cells from cultures of J2E erythroid cells is linked with karyotypic abnormalities

U Keil, SJ Busfield, TJ Farr, J Papadimitriou, AR Green, CG Begley and SP Klinken
Department of Biochemistry, University of Western Australia, Nedlands.

J2E cells are an erythroid cell line immortalized at the proerythroblast stage of differentiation by the J2 retrovirus which contains the raf and myc oncogenes. In response to erythropoietin, these cells terminally differentiate into mature, hemoglobin-producing erythroid cells. We have shown previously that B cells overexpressing raf and myc acquired the phenotype of macrophages, and here we demonstrate that, under adverse growth conditions, myeloid cells can also emerge from J2E cultures. Morphologically, ultrastructurally, and by cytochemical analyses, these cells resembled monocytic precursor cells at different stages of differentiation. They no longer responded to erythropoietin, failed to express an erythroid-specific surface antigen, and ceased producing transcripts for globin genes, GATA-1 and SCL. Most of the converted cells displayed surface antigens typically found on myeloid cells and in vivo produced histiocytomas with severe cachexia, instead of erythroleukemias. All of the myeloid convertants had karyotypic abnormalities, and we speculate that these mutations may have triggered the transition from erythroid to myeloid phenotype. Overexpression of raf and myc oncogenes may have generated genetic instability, which then influenced the commitment of cells to specific lineages.


This article has been cited by other articles:


Home page
J Biol ChemHome page
L. N. Winteringham, R. Endersby, S. Kobelke, R. K. McCulloch, J. H. Williams, J. Stillitano, S. M. Cornwall, E. Ingley, and S. P. Klinken
Myeloid Leukemia Factor 1 Associates with a Novel Heterogeneous Nuclear Ribonucleoprotein U-like Molecule
J. Biol. Chem., December 15, 2006; 281(50): 38791 - 38800.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J.-P. Lalonde, R. Lim, E. Ingley, P. A. Tilbrook, M. J. Thompson, R. McCulloch, J. G. Beaumont, C. Wicking, H. J. Eyre, G. R. Sutherland, et al.
HLS5, a Novel RBCC (Ring Finger, B Box, Coiled-coil) Family Member Isolated from a Hemopoietic Lineage Switch, Is a Candidate Tumor Suppressor
J. Biol. Chem., February 27, 2004; 279(9): 8181 - 8189.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
R. Lim, L. N. Winteringham, J. H. Williams, R. K. McCulloch, E. Ingley, J. Y.-H. Tiao, J.-P. Lalonde, S. Tsai, P. A. Tilbrook, Y. Sun, et al.
MADM, a Novel Adaptor Protein That Mediates Phosphorylation of the 14-3-3 Binding Site of Myeloid Leukemia Factor 1
J. Biol. Chem., October 25, 2002; 277(43): 40997 - 41008.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Yamada, M. Abe, T. Higashi, H. Yamamoto, F. Kihara-Negishi, T. Sakurai, T. Shirai, and T. Oikawa
Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells
Blood, April 15, 2001; 97(8): 2300 - 2307.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. S. Sayer, P. A. Tilbrook, A. Spadaccini, E. Ingley, M. K. Sarna, J. H. Williams, N. C. Andrews, and S. P. Klinken
Ectopic Expression of Transcription Factor NF-E2 Alters the Phenotype of Erythroid and Monoblastoid Cells
J. Biol. Chem., August 18, 2000; 275(33): 25292 - 25298.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
J. H. Williams, L. N. Daly, E. Ingley, J. G. Beaumont, P. A. Tilbrook, J.-P. Lalonde, J. P. Stillitano, and S. P. Klinken
HLS7, a hemopoietic lineage switch gene homologous to the leukemia-inducing gene MLF1
EMBO J., October 15, 1999; 18(20): 5559 - 5566.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
P. A. Tilbrook, E. Ingley, J. H. Williams, M. L. Hibbs, and S. P. Klinken
Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells
EMBO J., April 1, 1997; 16(7): 1610 - 1619.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
P. A. Tilbrook, T. Bittorf, S. J. Busfield, D. Chappell, and S. P. Klinken
Disrupted Signaling in a Mutant J2E Cell Line That Shows Enhanced Viability, but Does Not Proliferate or Differentiate, with Erythropoietin
J. Biol. Chem., February 16, 1996; 271(7): 3453 - 3459.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. S. Sayer, P. A. Tilbrook, A. Spadaccini, E. Ingley, M. K. Sarna, J. H. Williams, N. C. Andrews, and S. P. Klinken
Ectopic Expression of Transcription Factor NF-E2 Alters the Phenotype of Erythroid and Monoblastoid Cells
J. Biol. Chem., August 18, 2000; 275(33): 25292 - 25298.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.